Predicting the subcellular localization of viral proteins within a mammalian host cell

Virology Journal

Volumn 3, Issue , 2006, Pages

  Scott, M S ^a   Oomen, R ^b   Thomas, D Y ^c   Hallett, M T ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Sanofi Pasteur   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EUKARYOTIC CELL; HOST CELL; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN TARGETING; VACCINIA VIRUS;

COMPUTATIONAL BIOLOGY; CYTOMEGALOVIRUS; GENOME, HUMAN; GENOME, VIRAL; HUMANS; INTRACELLULAR SPACE; PROTEIN SORTING SIGNALS; PROTEINS; VACCINIA VIRUS; VIRAL PROTEINS;

EUKARYOTA; MAMMALIA; PROKARYOTA;

EID: 33745042748     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-24     Document Type: Article

References (75)

1. Gershburg E, Marschall M, Hong K, Pagano JS: Expression and localization of the Epstein-Barr virus-encoded protein kinase. J Virol 2004, 78:12140-12146.
2. Miyazaki Y, Takamatsu T, Nosaka T, Fujita S, Martin TE, Hatanaka M: The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23. Exp Cell Res 1995, 219:93-101.
3. Almazan F, Tscharke DC, Smith GL: The vaccinia virus superoxide dismutase-like protein (A45R) is a virion component that is nonessential for virus replication. J Virol 2001, 75:7018-7029.
4. Lilley BN, Ploegh HL: A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004, 429:834-840.
5. Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL: Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996, 384:432-438.
6. Atalay R, Zimmermann A, Wagner M, Borst E, Benz C, Messerle M, Hengel H: Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 2002, 76:8596-8608.
7. Boya P, Pauleau AL, Poncet D, Gonzalez-Polo RA, Zamzami N, Kroemer G: Viral proteins targeting mitochondria: controlling cell death. Biochim Biophys Acta 2004, 1659:178-189.
8. Everett H, McFadden G: Viruses and apoptosis: meddling with mitochondria. Virology 2001, 288:1-7.
9. da Fonseca FG, Silva RL, Marques JT, Ferreira PC, Kroon EG: The genome of cowpox virus contains a gene related to those encoding the epidermal growth factor, transforming growth factor alpha and vaccinia growth factor. Virus Genes 1999, 18:151-160.
10. Upton C, Mossman K, McFadden G: Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 1992, 258:1369-1372.
11. Donnes P, Hoglund A: Predicting protein subcellular localization: past, present, and future. Genomics Proteomics Bioinformatics 2004, 2:209-215.
12. Feng ZP: An overview on predicting the subcellular location of a protein. In Silico Biol 2002, 2:291-303.
13. Reinhardt A, Hubbard T: Using neural networks for prediction of the subcellular location of proteins. Nucleic Acids Res 1998, 26:2230-2236.
14. Hua S, Sun Z: Support vector machine approach for protein subcellular localization prediction. Bioinformatics 2001, 17:721-728.
15. Chou KC: Prediction of protein cellular attributes using pseudo-amino acid composition. Proteins 2001, 43:246-255.
16. Bendtsen JD, Nielsen H, von Heijne G, Brunak S: Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340:783-795.
17. Emanuelsson O, Nielsen H, Brunak S, von Heijne G: Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J Mol Biol 2000, 300:1005-1016.
18. Marcotte EM, Xenarios I, van Der Bliek AM, Eisenberg D: Localizing proteins in the cell from their phylogenetic profiles. Proc Natl Acad Sci U S A 2000, 97:12115-12120.
19. Lu Z, Szafron D, Greiner R, Lu P, Wishart DS, Poulin B, Anvik J, Macdonell C, Eisner R: Predicting subcellular localization of proteins using machine-learned classifiers. Bioinformatics 2004, 20:547-556.
20. Nakai K, Kanehisa M: A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics 1992, 14:897-911.
21. Drawid A, Gerstein M: A Bayesian system integrating expression data with sequence patterns for localizing proteins: comprehensive application to the yeast genome. J Mol Biol 2000, 301:1059-1075.
22. Scott MS, Thomas DY, Hallett MT: Predicting subcellular localization via protein motif co-occurrence. Genome Res 2004, 14:1957-1966.
23. Hoglund A, Donnes P, Blum T, Adolph HW, Kohlbacher O: Multi-Loc: prediction of protein subcellular localization using N-terminal targeting sequences, sequence motifs, and amino acid composition. Bioinformatics 2006.
24. Bairoch A, Apweiler R, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, Martin MJ, Natale DA, O'Donovan C, Redaschi N, Yeh LS: The Universal Protein Resource (UniProt). Nucleic Acids Res 2005, 33:D154-9.
25. Maggioni C, Braakman I: Synthesis and quality control of viral membrane proteins. Curr Top Microbiol Immunol 2005, 285:175-198.
26. Chazal N, Gerlier D: Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev 2003, 67:226-237.
27. Scott M, Lu G, Hallett M, Thomas DY: The Hera database and its use in the characterization of endoplasmic reticulum proteins. Bioinformatics 2004, 20:937-944.
28. Mulder NJ, Apweiler R, Attwood TK, Bairoch A, Barrell D, Bateman A, Binns D, Biswas M, Bradley P, Bork P, Bucher P, Copley RR, Courcelle E, Das U, Durbin R, Falquet L, Fleischmann W, Griffiths-Jones S, Haft D, Harte N, Hulo N, Kahn D, Kanapin A, Krestyaninova M, Lopez R, Letunic I, Lonsdale D, Silventoinen V, Orchard SE, Pagni M, Peyruc D, Ponting CP, Selengut JD, Servant F, Sigrist CJ, Vaughan R, Zdobnov EM: The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Res 2003, 31:315-318.
29. Mocarski ESJ: Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol 2004, 6:707-717.
30. Smith GL, Symons JA, Alcami A: Immune modulation by proteins secreted from cells infected by vaccinia virus. Arch Virol Suppl 1999, 15:111-129.
31. Stropes MP, Miller WE: Signaling and regulation of G-protein coupled receptors encoded by cytomegaloviruses. Biochem Cell Biol 2004, 82:636-642.
32. Dunlop LR, Oehlberg KA, Reid JJ, Avci D, Rosengard AM: Variola virus immune evasion proteins. Microbes Infect 2003, 5:1049-1056.
33. Huber MT, Tomazin R, Wisner T, Boname J, Johnson DC: Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol 2002, 76:5748-5758.
34. Michelson S: Consequences of human cytomegalovirus mimicry. Hum Immunol 2004, 65:465-475.
35. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ: Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A 1999, 96:9839-9844.
36. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S: Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A 2000, 97:1695-1700.
37. Pruitt KD, Tatusova T, Maglott DR: NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2005, 33:D501-4.
38. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402.
39. Chensue SW: Molecular machinations: chemokine signals in host-pathogen interactions. Clin Microbiol Rev 2001, 14:821-835.
40. Small I, Peeters N, Legeai F, Lurin C: Predotar: A tool for rapidly screening proteomes for N-terminal targeting sequences. Proteomics 2004, 4:1581-1590.
41. Krogh A, Larsson B, von Heijne G, Sonnhammer EL: Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305:567-580.
42. Fankhauser N, Maser P: Identification of GPI anchor attachment signals by a Kohonen self-organizing map. Bioinformatics 2005, 21:1846-1852.
43. Hulo N, Sigrist CJ, Le Saux V, Langendijk-Genevaux PS, Bordoli L, Gattiker A, De Castro E, Bucher P, Bairoch A: Recent improvements to the PROSITE database. Nucleic Acids Res 2004, 32:D134-7.
44. Cokol M, Nair R, Rost B: Finding nuclear localization signals. EMBO Rep 2000, 1:411-415.
45. Lorenzo MM, Galindo I, Griffiths G, Blasco R: Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. J Virol 2000, 74:10535-10550.
46. Sanderson CM, Parkinson JE, Hollinshead M, Smith GL: Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells. J Virol 1996, 70:905-914.
47. Gardner JD, Tscharke DC, Reading PC, Smith GL: Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. J Gen Virol 2001, 82:2083-2093.
48. Wilcock D, Duncan SA, Traktman P, Zhang WH, Smith GL: The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface. J Gen Virol 1999, 80 ( Pt 8):2137-2148.
49. Kettle S, Blake NW, Law KM, Smith GL: Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology 1995, 206:136-147.
50. Danescu J, Werenskiold AK: Post-transcriptional inhibition of the interleukin-1 binding protein B15R of vaccinia virus after coexpression of the related T1 protein. FEBS Lett 1995, 367:89-92.
51. Colamonici OR, Domanski P, Sweitzer SM, Larner A, Buller RM: Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 1995, 270:15974-15978.
52. Meiser A, Sancho C, Krijnse Locker J: Plasma membrane budding as an alternative release mechanism of the extracellular enveloped form of vaccinia virus from HeLa cells. J Virol 2003, 77:9931-9942.
53. Engelstad M, Smith GL: The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 1993, 194:627-637.
54. Symons JA, Adams E, Tscharke DC, Reading PC, Waldmann H, Smith GL: The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol 2002, 83:2833-2844.
55. Pires de Miranda M, Reading PC, Tscharke DC, Murphy BJ, Smith GL: The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J Gen Virol 2003, 84:2459-2471.
56. Maa JS, Rodriguez JF, Esteban M: Structural and functional characterization of a cell surface binding protein of vaccinia virus. J Biol Chem 1990, 265:1569-1577.
57. Beaud G: Vaccinia virus DNA replication: a short review. Biochimie 1995, 77:774-779.
58. Hu X, Wolffe EJ, Weisberg AS, Carroll LJ, Moss B: Repression of the A8L gene, encoding the early transcription factor 82-kilodalton subunit, inhibits morphogenesis of vaccinia virions. J Virol 1998, 72:104-112.
59. Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B: Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 1993, 195:732-744.
60. Reckmann I, Higley S, Way M: The vaccinia virus F17R protein interacts with actin. FEBS Lett 1997, 409:141-146.
61. Brown CK, Turner PC, Moyer RW: Molecular characterization of the vaccinia virus hemagglutinin gene. J Virol 1991, 65:3598-3606.
62. Bradley RR, Terajima M: Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein. Virus Res 2005.
63. Turner PC, Baquero MT, Yuan S, Thoennes SR, Moyer RW: The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin. Virology 2000, 272:267-280.
64. Xiang Y, Simpson DA, Spiegel J, Zhou A, Silverman RH, Condit RC: The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor. J Virol 1998, 72:7012-7023.
65. Kim HS, Lee YH, Min DS, Chang JS, Ryu SH, Ahn BY, Suh PG: Tyrosine phosphorylation of phospholipase C-gamma 1 by vaccinia virus growth factor. Virology 1995, 214:21-28.
66. Prichard MN, Lawlor H, Duke GM, Mo C, Wang Z, Dixon M, Kemble G, Kern ER: Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA. Virol J 2005, 2:55.
67. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML: A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997, 7:273-282.
68. Fraile-Ramos A, Pelchen-Matthews A, Kledal TN, Browne H, Schwartz TW, Marsh M: Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes. Traffic 2002, 3:218-232.
69. Ogawa-Goto K, Irie S, Omori A, Miura Y, Katano H, Hasegawa H, Kurata T, Sata T, Arao Y: An endoplasmic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegument protein encoded by UL48. J Virol 2002, 76:2350-2362.
70. Bradshaw PA, Duran-Guarino MR, Perkins S, Rowe JI, Fernandez J, Fry KE, Reyes GR, Young L, Foung SK: Localization of antigenic sites on human cytomegalovirus virion structural proteins encoded by UL48 and UL56. Virology 1994, 205:321-328.
71. Appleton BA, Loregian A, Filman DJ, Coen DM, Hogle JM: The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol Cell 2004, 15:233-244.
72. Michel D, Pavic I, Zimmermann A, Haupt E, Wunderlich K, Heuschmid M, Mertens T: The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J Virol 1996, 70:6340-6346.
73. Lee S, Park B, Ahn K: Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein. J Virol 2003, 77:2147-2156.
74. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL: Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A 1996, 93:11327-11333.
75. Lehner PJ, Karttunen JT, Wilkinson GW, Cresswell P: The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A 1997, 94:6904-6909.